• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹痛和抑郁,而非排便习惯,可预测功能性肠病患者的医疗保健利用情况。

Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders.

作者信息

Yu Vanessa, Ballou Sarah, Hassan Rifu, Singh Prashant, Shah Eric, Rangan Vikram, Iturrino Johanna, Nee Judy, Lembo Anthony

机构信息

Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Divison of Gastroenterology, Department of Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA.

出版信息

Am J Gastroenterol. 2021 Aug 1;116(8):1720-1726. doi: 10.14309/ajg.0000000000001306.

DOI:10.14309/ajg.0000000000001306
PMID:34003175
Abstract

INTRODUCTION

Patients with disorders of gut-brain interaction (DGBIs) are high users of health care. Past studies exploring predictors of utilization have lacked patient-level clinical data. The aim of the current study is to identify demographic, clinical, and psychological predictors of health care utilization in patients with irritable bowel syndrome (IBS), functional constipation (FC), and functional diarrhea (FDr).

METHODS

Consecutive new patients diagnosed with IBS, FC, and FDr (using Rome IV criteria) completed questionnaires assessing health care utilization as well as clinical and psychological symptoms. Health care utilization was assessed using a 13-item measure inquiring about the previous 6 months. Patient-Reported Outcome Measures Information System (PROMIS) was used to assess severity of abdominal pain, constipation, diarrhea, anxiety, depression, and sleep disturbance.

RESULTS

Of the 507 patients diagnosed with IBS, FC, or FDr, 434 completed the health care utilization questionnaire (mean age of 44 years, 79.5% female, and 73.5% IBS). In the final multivariable models, more severe abdominal pain and higher depression scores were significantly associated with increased utilization of (i) total outpatient visits, (ii) outpatient visits for gastrointestinal (GI) symptoms, and (iii) number of medications for GI symptoms. More severe abdominal pain was also significantly predictive of GI-related emergency department visits. Altered bowel habits were not consistent predictors of health care utilization.

DISCUSSION

Severity of abdominal pain and depressive symptoms, but not bowel habits, is a primary driver of increased care-seeking behavior in patients with IBS, FC, and FDr.

摘要

引言

肠道-脑互动障碍(DGBIs)患者是医疗保健的高使用者。过去探索医疗保健利用预测因素的研究缺乏患者层面的临床数据。本研究的目的是确定肠易激综合征(IBS)、功能性便秘(FC)和功能性腹泻(FDr)患者医疗保健利用的人口统计学、临床和心理预测因素。

方法

连续诊断为IBS、FC和FDr(使用罗马IV标准)的新患者完成了评估医疗保健利用以及临床和心理症状的问卷。使用一项13项指标的测量方法评估前6个月的医疗保健利用情况。患者报告结局测量信息系统(PROMIS)用于评估腹痛、便秘、腹泻、焦虑、抑郁和睡眠障碍的严重程度。

结果

在507例诊断为IBS、FC或FDr的患者中,434例完成了医疗保健利用问卷(平均年龄44岁,79.5%为女性,73.5%为IBS患者)。在最终的多变量模型中,更严重的腹痛和更高的抑郁评分与以下方面的利用增加显著相关:(i)门诊总就诊次数,(ii)胃肠道(GI)症状的门诊就诊次数,以及(iii)GI症状的用药数量。更严重的腹痛也是胃肠道相关急诊科就诊的显著预测因素。排便习惯改变并非医疗保健利用的一致预测因素。

讨论

腹痛和抑郁症状的严重程度而非排便习惯是IBS、FC和FDr患者寻求医疗行为增加的主要驱动因素。

相似文献

1
Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders.腹痛和抑郁,而非排便习惯,可预测功能性肠病患者的医疗保健利用情况。
Am J Gastroenterol. 2021 Aug 1;116(8):1720-1726. doi: 10.14309/ajg.0000000000001306.
2
Similarities and differences between IBS-C and FC with regards to symptomatology, sleep quality and psychological attributes.肠易激综合征便秘型和功能性便秘在症状、睡眠质量和心理特征方面的异同。
J Formos Med Assoc. 2020 Jan;119(1 Pt 1):75-80. doi: 10.1016/j.jfma.2019.02.017. Epub 2019 Mar 25.
3
Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation.疼痛或轻度疼痛性便秘?替代肠易激综合征便秘型与功能性便秘分类的一种有用临床方法。
Dig Dis Sci. 2018 Jul;63(7):1763-1773. doi: 10.1007/s10620-018-4995-6. Epub 2018 Feb 28.
4
A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.一种基于胃肠道症状和心理特征对 IBS 患者进行分类和亚组的新方法。
Am J Gastroenterol. 2021 Feb 1;116(2):372-381. doi: 10.14309/ajg.0000000000000975.
5
Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.肠易激综合征伴混合排便习惯型的症状特征。
Neurogastroenterol Motil. 2014 Jan;26(1):36-45. doi: 10.1111/nmo.12220. Epub 2013 Aug 29.
6
Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study.腹痛的表现和特征因肠易激综合征亚型而异:一项全国性基于人群的研究结果。
Am J Gastroenterol. 2020 Feb;115(2):294-301. doi: 10.14309/ajg.0000000000000502.
7
What Is Unspecified Functional Bowel Disorder? A Commonly Seen, Rarely Recognized, and Poorly Understood Diagnosis.未特定功能性肠紊乱是什么?一种常见但鲜为人知且了解甚少的诊断。
Am J Gastroenterol. 2023 Aug 1;118(8):1402-1409. doi: 10.14309/ajg.0000000000002281. Epub 2023 Apr 13.
8
Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.根据罗马 IV 标准,与功能性腹泻或功能性便秘相比,肠易激综合征患者的心理困扰和躯体化更为严重。
Neurogastroenterol Motil. 2021 Oct;33(10):e14121. doi: 10.1111/nmo.14121. Epub 2021 Mar 14.
9
Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.用于评估临床试验中治疗效果的肠易激综合征症状日记的开发:基础定性研究。
Value Health. 2017 Apr;20(4):618-626. doi: 10.1016/j.jval.2016.11.001. Epub 2017 Jan 3.
10
Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.罗马 IV 与罗马 III 肠易激综合征症状稳定性比较。
Am J Gastroenterol. 2021 Feb 1;116(2):362-371. doi: 10.14309/ajg.0000000000000946.

引用本文的文献

1
The Role of the Nurse in the Management of Irritable Bowel Syndrome: A Narrative Review.护士在肠易激综合征管理中的作用:一项叙述性综述
Transl Med UniSa. 2023 Dec 22;25(1):28-37. doi: 10.37825/2239-9747.1043. eCollection 2023.
2
The Impact of Antispasmodic Use on Abdominal Pain and Opioid Use in Inflammatory Bowel Disease: A Population-Based Study.抗痉挛药物使用对炎症性肠病腹痛及阿片类药物使用的影响:一项基于人群的研究
Aliment Pharmacol Ther. 2025 Jun;61(12):1944-1956. doi: 10.1111/apt.70147. Epub 2025 Apr 11.
3
Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis.
胰高血糖素样肽-1受体激动剂改善肠易激综合征:一项系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2025 Mar 11;16:1548346. doi: 10.3389/fendo.2025.1548346. eCollection 2025.
4
Gut dysbiosis impacts the immune system and promotes prostate cancer.肠道菌群失调会影响免疫系统并促进前列腺癌的发生。
Immunol Lett. 2024 Aug;268:106883. doi: 10.1016/j.imlet.2024.106883. Epub 2024 Jun 8.
5
An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with Constipation.替那诺尔治疗便秘型肠易激综合征对内脏高敏感性影响的概述
Clin Exp Gastroenterol. 2024 Apr 10;17:87-96. doi: 10.2147/CEG.S454526. eCollection 2024.
6
The efficacy and neural mechanism of acupuncture therapy in the treatment of visceral hypersensitivity in irritable bowel syndrome.针刺疗法治疗肠易激综合征内脏高敏感性的疗效及神经机制
Front Neurosci. 2023 Sep 4;17:1251470. doi: 10.3389/fnins.2023.1251470. eCollection 2023.
7
Chronic Pain and Mood Disorders Are Not Barriers to Symptom Improvement Under Collaborative Co-managed Care (C).慢性疼痛和情绪障碍并不会成为协作共管式医疗(C)下症状改善的障碍。
Dig Dis Sci. 2023 Sep;68(9):3569-3572. doi: 10.1007/s10620-023-08055-4. Epub 2023 Aug 4.
8
Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead.多组学在腹痛和肠易激综合征的诊断评估和管理中的生物标志物方法:未来的方向。
Gut Microbes. 2023 Jan-Dec;15(1):2195792. doi: 10.1080/19490976.2023.2195792.
9
Role of hippocampal circKcnk9 in visceral hypersensitivity and anxiety comorbidity of irritable bowel syndrome.海马体环状Kcnk9在肠易激综合征内脏高敏感性和焦虑共病中的作用。
Front Cell Neurosci. 2022 Nov 17;16:1010107. doi: 10.3389/fncel.2022.1010107. eCollection 2022.